Search research articles
Contact Us
Filters
Showing results (31-40 of 43) with videos related to
Page
of 5
Sort By:
International Journal of Molecular Sciences
|
April 14, 2026
Quaternary Phosphonium Salts Outperformed Vemurafenib (PLX) and Etoposide Against BRAF<sup>V600D,V600E</sup> PLX-Resistant Melanoma and MDR Neuroblastoma, Exhibiting No/Low Toxicity on 3T3/HaCaT Cells
Silvana Alfei, Maria Grazia Signorello, Sara Tirendi, et al.
Molecules (Basel, Switzerland)
|
February 23, 2020
New Hybrid Pyrazole and Imidazopyrazole Antinflammatory Agents Able to Reduce ROS Production in Different Biological Targets
Chiara Brullo, Matteo Massa, Federica Rapetti, et al.
European Journal of Medicinal Chemistry
|
February 22, 2013
Synthesis, in vitro antiplatelet activity and molecular modelling studies of 10-substituted 2-(1-piperazinyl)pyrimido[1,2-a]benzimidazol-4(10H)-ones
Mario Di Braccio, Giancarlo Grossi, Maria Grazia Signorello, et al.
Nanomaterials (Basel, Switzerland)
|
September 27, 2024
The Remarkable and Selective In Vitro Cytotoxicity of Synthesized Bola-Amphiphilic Nanovesicles on Etoposide-Sensitive and -Resistant Neuroblastoma Cells
Silvana Alfei, Paolo Giannoni, Maria Grazia Signorello, et al.
Journal of Human Hypertension
|
March 24, 2021
Usefulness of the corporate wellness projects in primary prevention at the population level: a study on the prevalence, awareness, and control of hypertension in the Ferrari company
Alessandro Biffi, Giovanna Gallo, Fredrick Fernando, et al.
International Journal of Molecular Sciences
|
May 11, 2024
Structure-Activity Relationship Studies on Highly Functionalized Pyrazole Hydrazones and Amides as Antiproliferative and Antioxidant Agents
Matteo Lusardi, Maria Grazia Signorello, Eleonora Russo, et al.
Journal of Medicinal Chemistry
|
May 16, 2007
Synthesis and in vitro antiplatelet activity of new 4-(1-piperazinyl)coumarin derivatives. Human platelet phosphodiesterase 3 inhibitory properties of the two most effective compounds described and molecular modeling study on their interactions with phosphodiesterase 3A catalytic site
Giorgio Roma, Mario Di Braccio, Giancarlo Grossi, et al.
Biology of the Cell
|
March 15, 2018
Extramitochondrial energy production in platelets
Silvia Ravera, Maria Grazia Signorello, Martina Bartolucci, et al.
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension
|
November 25, 2021
Relationship Between Cardiorespiratory Fitness, Baseline Blood Pressure and Hypertensive Response to Exercise in the Ferrari Corporate Population
Alessandro Biffi, Giovanna Gallo, Fredrick Fernando, et al.
Chemmedchem
|
February 22, 2023
Scouting Different Phosphodiesterase 4 Inhibitor Chemotypes in Silico To Guide the Design of Anti-inflammatory/Antioxidant Agents
Elena Cichero, Federica Rapetti, Matteo Lusardi, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 43) with videos related to
Sort By:
Page
of 5
International Journal of Molecular Sciences
|
April 14, 2026
Quaternary Phosphonium Salts Outperformed Vemurafenib (PLX) and Etoposide Against BRAF<sup>V600D,V600E</sup> PLX-Resistant Melanoma and MDR Neuroblastoma, Exhibiting No/Low Toxicity on 3T3/HaCaT Cells
Silvana Alfei, Maria Grazia Signorello, Sara Tirendi, et al.
Molecules (Basel, Switzerland)
|
February 23, 2020
New Hybrid Pyrazole and Imidazopyrazole Antinflammatory Agents Able to Reduce ROS Production in Different Biological Targets
Chiara Brullo, Matteo Massa, Federica Rapetti, et al.
European Journal of Medicinal Chemistry
|
February 22, 2013
Synthesis, in vitro antiplatelet activity and molecular modelling studies of 10-substituted 2-(1-piperazinyl)pyrimido[1,2-a]benzimidazol-4(10H)-ones
Mario Di Braccio, Giancarlo Grossi, Maria Grazia Signorello, et al.
Nanomaterials (Basel, Switzerland)
|
September 27, 2024
The Remarkable and Selective In Vitro Cytotoxicity of Synthesized Bola-Amphiphilic Nanovesicles on Etoposide-Sensitive and -Resistant Neuroblastoma Cells
Silvana Alfei, Paolo Giannoni, Maria Grazia Signorello, et al.
Journal of Human Hypertension
|
March 24, 2021
Usefulness of the corporate wellness projects in primary prevention at the population level: a study on the prevalence, awareness, and control of hypertension in the Ferrari company
Alessandro Biffi, Giovanna Gallo, Fredrick Fernando, et al.
International Journal of Molecular Sciences
|
May 11, 2024
Structure-Activity Relationship Studies on Highly Functionalized Pyrazole Hydrazones and Amides as Antiproliferative and Antioxidant Agents
Matteo Lusardi, Maria Grazia Signorello, Eleonora Russo, et al.
Journal of Medicinal Chemistry
|
May 16, 2007
Synthesis and in vitro antiplatelet activity of new 4-(1-piperazinyl)coumarin derivatives. Human platelet phosphodiesterase 3 inhibitory properties of the two most effective compounds described and molecular modeling study on their interactions with phosphodiesterase 3A catalytic site
Giorgio Roma, Mario Di Braccio, Giancarlo Grossi, et al.
Biology of the Cell
|
March 15, 2018
Extramitochondrial energy production in platelets
Silvia Ravera, Maria Grazia Signorello, Martina Bartolucci, et al.
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension
|
November 25, 2021
Relationship Between Cardiorespiratory Fitness, Baseline Blood Pressure and Hypertensive Response to Exercise in the Ferrari Corporate Population
Alessandro Biffi, Giovanna Gallo, Fredrick Fernando, et al.
Chemmedchem
|
February 22, 2023
Scouting Different Phosphodiesterase 4 Inhibitor Chemotypes in Silico To Guide the Design of Anti-inflammatory/Antioxidant Agents
Elena Cichero, Federica Rapetti, Matteo Lusardi, et al.
Page
of 5